Effect of gold therapy on CD5+B-cells an
✍
J. Hassan; C. Feighery; B. Bresnihan; A. Whelan
📂
Article
📅
1991
🏛
Springer
🌐
English
⚖ 346 KB
Circulating CD5+ B-cell levels in 15 patients with rheumatoid arthritis (RA) not receiving remittive therapy was significantly increased when compared to 17 normal controls (mean +/- SE: RA, 19.7 +/- 2.85%; controls, 11.6 +/- 1.67%; P less than 0.02). In contrast, 24 patients with RA receiving gold